Porton Pharma Solutions Ltd. is proud to announce that it has made the top quartile of the S&P Corporate Sustainability Assessment for the first time. On February 28, S&P Global released a new set of S&P Global ESG Scores, where …
Part of the CPHI global network, the event brings together over 3,000 attendees from over 70 countries for 3 days of
Schedule to meet with J-STAR Research at DCAT Week 2023
Date: March 20-23, 2023
Location: New York, NY
DCAT Week is the premier event held annually in New York City for companies engaged in the Global Bio/Pharmaceutical Manufacturing Value Chain.
Schedule a meeting to talk with us at MARM 2023
The New York ACS along with its partners at the The Graduate Center of the City University of New York and St. John’s University are proud to present the 2023 …
Porton’s recognition by Roche is a testament to the high-quality service and technical expertise that comes with working with a leading global end-to-end CDMO.
Shanghai China (December 16, 2022) – Porton Pharma Solutions (hereinafter referred to as Porton) was recently …
J-STAR Research and Porton Pharma Solutions Ltd. are excited to be exhibiting at this year’s American Association of Pharmaceutical Scientists (AAPS) Annual Meeting at the Boston Convention Center on October 16th – 19th! Stay tuned for more information regarding our …
The year 2022 is an important milestone for Porton. Despite of the uncertainties of the external environment, we always keep in mind Porton’s mission of “Enabling public’s early access to good medicines” to overcome those challenges and ensure delivery through …
PORTON PHARMA SOLUTIONS LTD., a world leading CDMO (Hereafter PORTON) announces plans to invest into a new state of the Art cGMP/API facility inside, Life Science Park Mengeš, Slovenia currently owned and operated by Lek Pharmaceuticals d.d., part of NOVARTIS
PORTON PHARMA SOLUTIONS LTD., a world leading CDMO (Hereafter PORTON) announces plans to invest into a new state of the Art cGMP/API facility inside, Life Science Park Mengeš, Slovenia currently owned and operated by Lek Pharmaceuticals d.d., part of NOVARTIS …
Porton is excited to announce construction of a new, state-of-the-art Crystallization and Drug Product facility in Cranbury, NJ. The new building is projected to open in Q4 of 2022. This facility will be cGMP capable for Drug Product supplies, and …
We are very excited to announce the technical program of Pharma Crystallization Summit 2022. This year’s Summit is in-person only and the seats are limited. We cordially invite CMC leaders/managers of drug development programs, API crystallization experts or solution …
